![]() |
Name |
GKK1032A2
|
Molecular Formula | C32H41NO4 | |
IUPAC Name* |
13-ethenyl-19-hydroxy-5,7,9,11,13-pentamethyl-2-oxa-18-azahexacyclo[19.2.2.13,10.116,19.04,9.014,27]heptacosa-1(23),11,21,24-tetraene-15,17-dione
|
|
SMILES |
C=CC1(C)C=C(C)C2C3C(Oc4ccc(cc4)CC4(O)CC(C(=O)N4)C(=O)C31)C1C(C)CC(C)CC21C
|
|
InChI |
InChI=1S/C32H41NO4/c1-7-30(5)14-19(4)24-23-26(30)27(34)22-16-32(36,33-29(22)35)15-20-8-10-21(11-9-20)37-28(23)25-18(3)12-17(2)13-31(24,25)6/h7-11,14,17-18,22-26,28,36H,1,12-13,15-16H2,2-6H3,(H,33,35)/t17-,18+,22+,23+,24-,25+,26+,28+,30+,31+,32-/m1/s1
|
|
InChIKey |
IQOSMPPPZDUYCT-ZIEHWXONSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 503.68 | ALogp: | 5.1 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 75.6 | Aromatic Rings: | 7 |
Heavy Atoms: | 37 | QED Weighted: | 0.397 |
Caco-2 Permeability: | -4.814 | MDCK Permeability: | 0.00008380 |
Pgp-inhibitor: | 0.973 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.018 | 20% Bioavailability (F20%): | 0.046 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.451 | Plasma Protein Binding (PPB): | 97.86% |
Volume Distribution (VD): | 1.661 | Fu: | 1.79% |
CYP1A2-inhibitor: | 0.029 | CYP1A2-substrate: | 0.859 |
CYP2C19-inhibitor: | 0.754 | CYP2C19-substrate: | 0.908 |
CYP2C9-inhibitor: | 0.588 | CYP2C9-substrate: | 0.16 |
CYP2D6-inhibitor: | 0.096 | CYP2D6-substrate: | 0.154 |
CYP3A4-inhibitor: | 0.977 | CYP3A4-substrate: | 0.867 |
Clearance (CL): | 15.852 | Half-life (T1/2): | 0.011 |
hERG Blockers: | 0.318 | Human Hepatotoxicity (H-HT): | 0.488 |
Drug-inuced Liver Injury (DILI): | 0.657 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.997 | Maximum Recommended Daily Dose: | 0.924 |
Skin Sensitization: | 0.029 | Carcinogencity: | 0.041 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.943 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004852 | ![]() |
0.823 | D0W2EK | ![]() |
0.233 | ||
ENC003349 | ![]() |
0.772 | D0E9KA | ![]() |
0.227 | ||
ENC003989 | ![]() |
0.739 | D0V4WD | ![]() |
0.224 | ||
ENC003503 | ![]() |
0.714 | D0I5DS | ![]() |
0.224 | ||
ENC003851 | ![]() |
0.683 | D0D2TN | ![]() |
0.224 | ||
ENC005320 | ![]() |
0.667 | D0F1EX | ![]() |
0.221 | ||
ENC003137 | ![]() |
0.616 | D09WYX | ![]() |
0.218 | ||
ENC005770 | ![]() |
0.547 | D0CZ1Q | ![]() |
0.215 | ||
ENC005366 | ![]() |
0.449 | D08PIQ | ![]() |
0.215 | ||
ENC003606 | ![]() |
0.449 | D04SFH | ![]() |
0.214 |